Showing 371-380 of 7712 results for "".
What to Look for in an Investment Advisor
https://practicaldermatology.com/topics/practice-management/what-to-look-for-in-an-investment-advisor/21018/Avoid choosing the wrong firm.Chemoprevention Strategies for AK Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/chemoprevention-strategies-for-ak-patients/18822/Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as well as for prevention and management. He discusses the importance of sun protection and photodamage prevention, and says the key to treatment and maintenance is combination therapCosmeceutical Advances in 2016
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceutical-advances-in-2016/18622/Suneel Chilukuri, MD discusses recent advances in the cosmeceutical market including a new topical formulated to protect the skin from UVA/UVB damage as well as from infrared radiation, a skin brightening topical formulated to carry retinol deeper into the skin, and a topical hyaluronic acid productPediatric Atopic Dermatitis And Psoriasis
https://practicaldermatology.com/topics/psoriasis/pediatric-atopic-dermatitis-and-psoriasis/18631/Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many children remain undertreated for their eczema despite the availability of effective treatments and a number of topical and systemic products on the horizon. Dr. Eichenfield also proUpdates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Complex Adaptive Systems Approach: Continuous Quality Improvement Assessments Applied to Dermatology
https://practicaldermatology.com/topics/general-topics/complex-adaptive-systems-approach-continuous-quality-improvement-assessments-applied-to-dermatology/21103/Part II- Applied to Systemic Lupus ErythematosusThe Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.The Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Valeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Otezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for p